A detailed history of Rockbridge Investment Management, Lcc transactions in Abbott Laboratories stock. As of the latest transaction made, Rockbridge Investment Management, Lcc holds 1,827 shares of ABT stock, worth $215,512. This represents 0.03% of its overall portfolio holdings.

Number of Shares
1,827
Holding current value
$215,512
% of portfolio
0.03%

Shares

15 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 01, 2024

BUY
$100.07 - $118.13 $182,827 - $215,823
1,827 New
1,827 $208 Million
Q1 2024

May 15, 2024

SELL
$109.52 - $120.96 $27,380 - $30,240
-250 Reduced 12.04%
1,827 $208 Million
Q4 2023

Feb 14, 2024

SELL
$90.19 - $110.4 $50,416 - $61,713
-559 Reduced 21.21%
2,077 $229 Million
Q3 2023

May 28, 2024

SELL
$95.53 - $114.62 $1,241 - $1,490
-13 Reduced 0.61%
2,130 $206,000
Q1 2023

May 28, 2024

SELL
$96.86 - $114.01 $96,860 - $114,010
-1,000 Reduced 31.82%
2,143 $217,000
Q4 2022

May 28, 2024

BUY
$95.06 - $111.52 $95,060 - $111,520
1,000 Added 46.66%
3,143 $345,000
Q3 2022

May 28, 2024

SELL
$96.76 - $112.03 $20,513 - $23,750
-212 Reduced 9.0%
2,143 $207,000
Q2 2022

May 28, 2024

SELL
$102.07 - $123.37 $28,681 - $34,666
-281 Reduced 10.66%
2,355 $255,000
Q1 2022

May 28, 2024

BUY
$114.02 - $139.04 $92,242 - $112,483
809 Added 44.28%
2,636 $311,000
Q4 2021

Feb 14, 2022

BUY
$115.53 - $141.46 $30,499 - $37,345
264 Added 11.13%
2,636 $371,000
Q3 2021

Nov 12, 2021

BUY
$116.66 - $129.06 $3,499 - $3,871
30 Added 1.28%
2,372 $280,000
Q2 2021

Aug 05, 2021

BUY
$105.79 - $124.53 $6,876 - $8,094
65 Added 2.85%
2,342 $272,000
Q1 2021

May 20, 2021

SELL
$108.84 - $128.23 $1,850 - $2,179
-17 Reduced 0.74%
2,277 $273,000
Q3 2020

Nov 03, 2020

BUY
$91.64 - $111.29 $9,164 - $11,129
100 Added 4.56%
2,294 $250,000
Q2 2020

Aug 20, 2020

BUY
$76.57 - $98.0 $167,994 - $215,012
2,194 New
2,194 $201,000

Others Institutions Holding ABT

About ABBOTT LABORATORIES


  • Ticker ABT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Medical Devices
  • Shares Outstandng 1,751,219,968
  • Market Cap $207B
  • Description
  • Abbott Laboratories, together with its subsidiaries, discovers, develops, manufactures, and sells health care products worldwide. It operates in four segments: Established Pharmaceutical Products, Diagnostic Products, Nutritional Products, and Medical Devices. The Established Pharmaceutical Products segment provides generic pharmaceuticals for t...
More about ABT
Track This Portfolio

Track Rockbridge Investment Management, Lcc Portfolio

Follow Rockbridge Investment Management, Lcc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rockbridge Investment Management, Lcc, based on Form 13F filings with the SEC.

News

Stay updated on Rockbridge Investment Management, Lcc with notifications on news.